Behold world! The clinical trials for CutoSense’s WoundWatch wound assessment systems have officially started! This will be the first truly disruptive innovation in wound care since the invention of the camera.
TCAF Member Finnadvance raises a €1.2 million seed funding round to expand to foreign markets. For more information, please read the press release here.
EpiHeart raised more than 200 % of the equity funding target in the funding campaign organised on the Invesdor platform.
Please note that due to the ongoing Covid-19 outbreak, the TCAF Networking Event in Tampere on March 19 is cancelled.
Hope to see you at a future event when things have returned to normal!
Tissue Cure Alliance Finland (TCAF) will host a networking afternoon in Tampere in March. At the event you can experience live demonstrations, watch presentations and interact with other people. If you are interested in the field of tissue regeneration and wound care, this is the event for you! The purpose of the event is to get together, exchange knowledge and ideas.
Free snacks are offered!
Thursday March 19th 2020 at 14:00. Tribe Tampere, Pinninkatu 47, Tampere. The event will be open until 17:00.
Please sign up for the event by sending an email to TCAF coordinator Andreas Slama, andreas.slama@tissuecure.fi as soon as possible, but no later than March 17th.
Tissue Cure Alliance Finland (TCAF) is a non-profit community for Finnish tissue regeneration and wound care companies and for research organisations. Sharing experiences and best practises is at the heart of the Alliance. In addition, the Alliance aims at promoting and marketing the products and solutions provided by its members.
The Alliance was founded in 2018 by Finnish start-up companies Askel Healthcare Oy, CutoSense Oy, Finnish Red Cross Blood Service, UPM Biomedicals and Åbo Akademi University.
For more information contact coordinator Andreas Slama, andreas.slama@tissuecure.fi or chairman Virpi Muhonen, virpi.muhonen@askelhealthcare.com or visit www.tissuecure.fi
A new research ecosystem has been set up in Finland in which the country’s leading research organisations, together with the Finnish Red Cross Blood Service, Orion Pharma and nanotechnology SMEs, are joining forces to develop new types of nanobiotechnological solutions for the treatment and early diagnostics of severe progressive diseases.
Read more on the Finnish Red Cross Blood Service webpage:
https://www.bloodservice.fi/news/new-pharmaceutical-research-utilising-nanobiotechnology-in-finland1
TCAF congratulates Askel Healthcare on their very successful crowdfunding efforts. We are looking forward to what wonders you will accomplish!
Read more on Askel Healthcares website:
https://askelhealthcare.com/successful-crowdfunding-round-onnistunut-joukkorahoituskierros
Tissue Cure Alliance Finland (TCAF) will host a networking afternoon in Turku in November. The purpose of the event is for people interested in or working within the field of tissue regeneration and wound care to get togenther, exchange knowledge and ideas.
Tissue Cure Alliance Finland
Tissue Cure Alliance Finland (TCAF) is a non-profit community for Finnish tissue regeneration and wound care companies and for research organisations. Sharing experiences and best practises is at the heart of the Alliance. In addition, the Alliance aims at promoting and marketing the products and solutions provided by its members. Background
The Alliance was founded in 2018 by Finnish start-up companies Askel Healthcare Oy, CutoSense Oy, Finnish Red Cross Blood Service, UPM Biomedicals and Åbo Akademi University. For more information contact coordinator Andreas Slama, andreas.slama@konfer.fi or chairman Virpi Muhonen, virpi.muhonen@askelhealthcare.com or visit www.tissuecure.fi
Come and visit our stand at the EBA on September 5th!
Tissue Cure Alliance Finland will have a stand at the European Burns Association congress at the Marina Congress Center in Helsinki on Thursday September 5th 2019.
https://www.upmbiomedicals.com/news-events/press-releases/2019/fibdex-receives-ce-mark/
